Mirum Pharmaceuticals, Inc. (MIRM) stock
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$91.95+0.37 (+0.40%)
Close on Nov 17, 2026Market cap $5.97BP/E –Yield –
Mirum Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Mirum Pharmaceuticals's price to book ratio was 26.6× on Jul 31, 2026, against 11.0× a year earlier. Over the last 5 years it ranged from 4.1× to 29.4×, with a median of 8.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 26.6× | +12.7 |
| 2025 | Dec 31, 2025 | 13.9× | +5.3 |
| 2024 | Dec 31, 2024 | 8.5× | +3.4 |
| 2023 | Dec 29, 2023 | 5.1× | +0.9 |
| 2022 | Dec 30, 2022 | 4.2× | −4.4 |
| 2021 | Dec 31, 2021 | 8.6× | +4.9 |
| 2020 | Dec 31, 2020 | 3.7× | −0.1 |
| 2019 | Dec 31, 2019 | 3.8× | – |
See a number that looks wrong?